跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HOVA EXPECTORANT - HSA Drug Approval Details
Approvals
/
HSA
/
HOVA EXPECTORANT
Approved
THERAPEUTIC
HOVA EXPECTORANT
HOVID BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
Jun 12, 1989
Approval ID
d88e26e6c91977d9
Company
HOVID BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
d88e26e6c91977d9
Drug Name
HOVA EXPECTORANT
Product Name
HOVA EXPECTORANT
Approval Number
SIN03251P
Approval Date
1989-06-12
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R05CA10
Atc Item Name
combinations
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
SODIUM CITRATE
57 mg/5 ml
DIPHENHYDRAMINE HCl
14 mg/5 ml
AMMONIUM CHLORIDE
135 mg/5 ml
AMMONIUM CHLORIDE
135 mg/5 ml
DIPHENHYDRAMINE HCl
14 mg/5 ml
SODIUM CITRATE
57 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 12, 1989
Approval ID
d88e26e6c91977d9
Type
Therapeutic
Back to HSA Approvals